Sign in

CIK 0000727510

  • Non-accelerated filer
  • Smaller reporting company

Viskase Holdings, Inc.

Sign in to watch
Ticker
VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222372868
Phone
+1 630-874-0700
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Former names
ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 37 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-01-23 Buchbinder Aby VP, Clinical Development Grant or award +3,748 79,246
2012-01-17 Buchbinder Aby VP, Clinical Development Grant or award +4,000 58,015
2012-01-17 Buchbinder Aby VP, Clinical Development Grant or award · Employee Stock Option (Right to Buy) +12,000 12,000
2011-11-08 Buchbinder Aby VP, Clinical Development Sale −2,700 $7.06 $19K 54,015
2011-09-15 Buchbinder Aby VP, Clinical Development Shares withheld for taxes −2,952 $8.33 $25K 56,715
2011-08-12 Buchbinder Aby VP, Clinical Development Grant or award +8,000 59,667

Page 1 of 1 · 6 trades